About Sharp Fluidics
Sharp Fluidics is a Healthcare company based in San Francisco (United States) founded in 2014 by Kenneth Trauner. Suture needle management systems are developed for safe surgical infusion. Sharp Fluidics has raised $12.75 million across 2 funding rounds. Sharp Fluidics has completed 1 acquisition, including neoSurgical. Sharp Fluidics offers products and services including NeoClose and Operative Armour. Its focus areas include Life Sciences, Surgical Instruments, Surgical Access and Closure and Surgical Sutures. Its legal entity is Sharp Fluidics Inc. Its competitors include VESTECK and Ethicon; 1 of its 2 listed competitors has raised funding.
Company details
The Sharp Fluidics is a developer of systems for safe infusion. It has developed the Operative Armour Suture Needle Management System, which centers on disposable, single-use needle traps that secure and cover both tips of each contaminated needle. The traps are attached to the off-the-shelf suture packs which enable the surgeons to self-dispense new needles from suture packs and then self-secure those needles in the Trap after completing a stitch without diverting their attention from the near-surgical field.
- Headquarters San Francisco, United States
- Founders Kenneth Trauner
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website sharpfluidics.com
- Social LinkedIn
- Legal Name Sharp Fluidics Inc
- Total Equity Funding$12.75M (USD)
in 2 rounds
- Latest Funding Round$6M (USD), Series A
May 2019
- Investments & Acquisitions
Products & Services of Sharp Fluidics
Sharp Fluidics offers a comprehensive portfolio of products and services, including NeoClose and Operative Armour.
System for efficient robotic and laparoscopic surgical closure.
Device for safe suture needle handling during surgeries.
Funding Insights of Sharp Fluidics
Sharp Fluidics has successfully raised a total of $12.75M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $6 million completed in May 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $12.75M
- Total Rounds 2
- Last Round Series A — $6M
- First Round $6.75M
(Mar 2018)
All 2 funding rounds of Sharp Fluidics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2019 | $6M | Series A | – | – | – |
| Mar 2018 | $6.75M | Series A | – | – | – |
People of Sharp Fluidics
2 people are tracked at Sharp Fluidics (2 in leadership).
| Name | Role | Group |
|---|---|---|
Kenneth Trauner | Founder & Chairman | Leadership |
Douglas Rimer | President | Leadership |
Complete people profiles for Sharp Fluidics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sharp Fluidics
Sharp Fluidics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include neoSurgical.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Laparoscopic surgical instruments for access, retraction, and closure are provided. | neosurgical.com | Galway, Ireland | 2008 | Apr 2020 | •••• |
Complete acquisition details for Sharp Fluidics
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Sharp Fluidics
4 dated milestones of Sharp Fluidics across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Sharp Fluidics is founded.
- Funding First funding round of $6.8M.
- Funding Latest funding round, Series A, of $6.0M.
- Acquisition Acquires neoSurgical.
Competitors of Sharp Fluidics
Sharp Fluidics has 2 listed competitors in our database, 1 of them funded. They include VESTECK and Ethicon.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| vesteck.com | 2019 | West Chester, United States | $12.86M | Developer of a device for the treatment of aortic aneurysms | ||
| ethicon.com | 1886 | Cincinnati, United States | Specializes in surgical sutures and wound closure devices. |
Detailed competitors of Sharp Fluidics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Sharp Fluidics
The website of Sharp Fluidics (sharpfluidics.com) receives about 1.3K visits a month.
- Monthly visits1.3K
▼ 13.1% vs previous month
Top companies in Medical Equipment & Supplies
3 companies that operate in the same segment as Sharp Fluidics (Medical Equipment & Supplies) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Robotic waterjet system for prostate tissue removal is developed. | 2009 | Redwood City, California, United States | USD 348.84 M | USD 308.05 M | 756 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 | ||
Injectable packaging, containment, and delivery solutions are manufactured. | 1923 | Exton, Pennsylvania, United States | USD 3.07 B | 10,600 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sharp Fluidics
Complete news archive for Sharp Fluidics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sharp Fluidics
Sharp Fluidics was founded in 2014 and raised its 1st funding round 4 years after it was founded.
Sharp Fluidics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Sharp Fluidics is a funded company, having raised a total of $12.75M across 2 funding rounds to date. The company's 1st funding round was a Series A of $6.75M, raised on Mar 2018.
The Sharp Fluidics is a developer of systems for safe infusion. It has developed the Operative Armour Suture Needle Management System, which centers on disposable, single-use needle traps that secure and cover both tips of each contaminated needle. The traps are attached to the off-the-shelf suture packs which enable the surgeons to self-dispense new needles from suture packs and then self-secure those needles in the Trap after completing a stitch without diverting their attention from the near-surgical field.
Sharp Fluidics offers NeoClose and Operative Armour.
Sharp Fluidics has made 1 acquisition, including neoSurgical.
Sharp Fluidics operates through Sharp Fluidics Inc.